Role of Intranasal Desmopressin in Clopidogrel-Induced Platelet Dysfunction

Introduction to Desmopressin Use

The French Working Group on Perioperative Haemostasis states that desmopressin's efficacy for antiplatelet agent reversal is "very uncertain" despite being frequently mentioned as a therapeutic option 1, 2, 3, 4

Clinical demonstration of desmopressin's efficacy in clopidogrel-treated patients is inadequate, with insufficient data on clinical outcomes such as mortality, morbidity, and quality of life 1, 2, 3
A meta-analysis of desmopressin's potential benefit in cardiac surgery showed limited relevance due to outdated data, small sample size, and lack of representation of non-elective surgery or clopidogrel use 1, 2
A small randomized trial failed to demonstrate that desmopressin reduces blood loss in patients on dual antiplatelet therapy undergoing coronary bypass 1, 2

Desmopressin increases von Willebrand factor and Factor VIII concentrations, theoretically compensating for clopidogrel's P2Y12 receptor blockade 5, 6

The standard dose of desmopressin is 0.3 μg/kg diluted in 50 mL saline infused intravenously over 30 minutes 5, 6, 7, 8

The French Working Group on Perioperative Haemostasis recommends considering desmopressin in trauma patients with intracranial hemorrhage on clopidogrel when platelet transfusion is unavailable or delayed (Grade 2C recommendation) 5, 6
Desmopressin may be considered in patients with documented platelet dysfunction on platelet function testing who require urgent intervention 5, 6
Desmopressin can be used as an adjunct to platelet transfusion to enhance recovery of normal platelet function 5, 6, 7

Significant adverse effects of desmopressin include systemic vasodilation, oliguria, hypervolemia, hyponatremia, and rare thromboembolic events 1, 2, 4
Fluid restriction is essential to prevent water intoxication, with evening fluid intake limited to ≤200 mL 8

Platelet transfusion remains the first-line treatment for clopidogrel-induced platelet dysfunction, with 10-15 platelet units suggested for aspirin plus clopidogrel combination 5, 6
The timing of platelet transfusion is critical, with a wait of at least 6 hours after the last clopidogrel dose to avoid transfused platelets being inactivated by the circulating active metabolite 1, 2, 3